Annovis faces financial challenges and questionable efficacy in Alzheimer's and Parkinson's trials, risking poor stock ...

Annovis has limited cash reserves and faces challenges in financing further trials, making the future of Buntanetap uncertain ...

Wolfe Research has recently reduced Otis Worldwide Corp (OTIS) stock to Peer Perform rating, as announced on October 8, 2024, according to Finviz. Earlier, on September 6, 2024, Morgan Stanley had ...

Carlisle Companies Incorporated (NYSE:CSL) today announced that it has entered into a definitive agreement to acquire the expanded polystyrene “EPS” i ...

The three-time cofounder of Splice, Blade, and GroupMe raised $5.5 million for his new startup SuppCo to help people find ...

Jamie Murray, an analyst with Shore Capital Markets in London, wrote in an email that the Irvine plant is now part of Avon ...